ANG Lifesciences

34.00
+0.42
(1.25%)
Market Cap
43.80 Cr
EPS
-7.65
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
63.17
52 Week low
29.85
PB Ratio
0.62
Debt to Equity
0.88
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,609.30 3,87,252.70 32.75 49,887.20 12.06 9,648 13.77 37.18
5,578.75 1,47,831.50 71.79 8,184.00 0.89 1,600 64.53 41.61
1,458.45 1,18,053.00 23.61 26,520.70 14.17 4,155 47.38 52.18
3,073.80 1,03,530.50 55.84 10,785.70 11.59 1,656 13.54 48.73
1,133.25 95,131.20 17.60 28,905.40 12.36 5,578 1.69 34.68
2,316.05 93,830.10 46.80 10,615.60 19.57 1,942 -16.38 41.13
2,030.00 92,083.50 32.29 20,141.50 19.94 1,936 38.82 50.83
900.80 91,305.70 20.00 19,831.50 13.82 3,831 29.92 44.90
30,768.30 65,837.00 48.94 6,097.20 10.80 1,201 16.01 61.26
1,097.40 64,730.30 18.08 29,559.20 17.55 3,169 -10.04 43.59
Growth Rate
Revenue Growth
-36.06 %
Net Income Growth
3,266.67 %
Cash Flow Change
-135.97 %
ROE
4,333.33 %
ROCE
-98.01 %
EBITDA Margin (Avg.)
-32.15 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
32
36
120
90
50
96
74
60
47
49
57
34
19
38
20
33
25
Expenses
31
33
90
70
44
83
62
50
44
50
50
32
21
36
20
31
27
EBITDA
2
4
30
20
6
13
12
10
3
-1
7
2
-2
2
-0
3
-2
Operating Profit %
5 %
9 %
25 %
22 %
11 %
13 %
16 %
16 %
6 %
-26 %
12 %
5 %
-10 %
4 %
-9 %
7 %
-9 %
Depreciation
0
0
1
1
2
3
2
2
2
3
2
2
2
2
2
2
2
Interest
1
1
1
2
2
4
3
3
4
2
2
2
3
4
2
2
2
Profit Before Tax
1
2
28
17
2
7
7
4
-3
-6
2
-3
-6
-4
-4
-1
-6
Tax
0
1
8
4
1
2
3
2
-1
-1
1
-0
-0
-0
-1
1
-1
Net Profit
0
1
20
13
1
5
4
3
-2
-5
2
-2
-6
-4
-3
-2
-5
EPS in ₹
0.42
2.30
38.66
12.41
1.29
5.16
3.99
2.20
-1.36
-3.63
1.41
-1.74
-4.52
-2.75
-2.35
-1.53
-3.98

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
291
278
242
Fixed Assets
93
88
58
Current Assets
193
183
173
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
198
190
184
Total Liabilities
291
278
242
Current Liabilities
166
162
145
Non Current Liabilities
41
29
22
Total Equity
84
86
76
Reserve & Surplus
69
69
59
Share Capital
10
13
13

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
0
0
Investing Activities
-44
-9
20
Operating Activities
25
26
-10
Financing Activities
20
-17
-10

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
71.01 %
71.07 %
71.09 %
71.14 %
71.15 %
71.15 %
71.15 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
70.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.94 %
25.53 %
26.62 %
25.87 %
25.66 %
25.76 %
25.56 %
26.13 %
26.23 %
26.09 %
25.29 %
25.62 %
25.48 %
25.45 %
25.92 %
Others
9.05 %
3.40 %
2.29 %
2.99 %
3.20 %
3.09 %
3.30 %
3.27 %
3.16 %
3.31 %
4.11 %
3.78 %
3.92 %
3.95 %
3.48 %
No of Share Holders
0
328
323
2,522
4,259
5,215
6,939
7,163
7,305
7,055
6,918
6,868
6,631
6,468
6,517

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 1.33 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 15, 2025, 13:15
Integrated Filing (Financial)
Feb 14, 2025, 18:13
UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024
Feb 14, 2025, 18:09
Board Meeting Outcome for Board Meeting Outcome For SUBMISSION OF UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024
Feb 14, 2025, 18:04
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Declaring Unaudited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31
Feb 06, 2025, 15:10
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 14, 2025, 15:36
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Dec 16, 2024, 18:48
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 16, 2024, 16:32
Financial Results For Quarter And Half Year Ended 30.09.2024.
Nov 14, 2024, 17:58
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.11.2024
Nov 14, 2024, 17:55
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Nov 07, 2024, 17:02
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 15, 2024, 11:45
Scrutinizer Report And Evoting Result For AGM 30.09.2024 Of ANG Lifesciences India Limited
Oct 02, 2024, 15:36
Disclosure under Regulation 30A of LODR
Oct 01, 2024, 19:03
Shareholder Meeting / Postal Ballot-Outcome of AGM
Oct 01, 2024, 18:38
Closure of Trading Window
Sep 25, 2024, 11:26
Reg. 34 (1) Annual Report.
Sep 07, 2024, 22:03
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Sep 07, 2024, 20:15
Book Closure For 18Th Annual General Meeting
Sep 07, 2024, 20:10
Notice Of AGM For FY 2023-24
Sep 07, 2024, 20:07
Unaudited Standalone And Consolidated Financial Result For Quarter Ended As At 30.06.2024
Aug 14, 2024, 18:42
Board Meeting Outcome for Outcome Of Board Meeting Dated 14.08.2024
Aug 14, 2024, 18:38
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Aug 14, 2024, 18:35
Board Meeting Intimation for Notice Of Board Meeting Under Reg. 29Of SEBI (LODR), 2015
Aug 07, 2024, 18:06
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 17, 2024, 17:29
Closure of Trading Window
Jun 29, 2024, 11:32
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.
Jun 27, 2024, 18:32
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jun 13, 2024, 17:42
Announcement under Regulation 30 (LODR)-Cessation
Jun 13, 2024, 17:38
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 30, 2024, 20:51
Financial Result For Quarter And Year Ended As At 31.03.2024
May 30, 2024, 18:52
Board Meeting Outcome for Outcome Of Board Meeting
May 30, 2024, 18:43
Announcement under Regulation 30 (LODR)-Meeting Updates
May 27, 2024, 18:04
Board Meeting Intimation for Approval Of Audited Financial Standalone And Consolidated Statements For Quarter And Year Ended 31.03.2024.
May 24, 2024, 17:31
Announcement under Regulation 30 (LODR)-Meeting Updates
May 13, 2024, 17:52
Disclosure And Intimation Of Non-Applicability Of SEBI Circular No SEBI/HO/DDHS/Clr/P /2018/744 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities.
Apr 30, 2024, 16:35
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Apr 30, 2024, 16:31
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apr 20, 2024, 12:00
Compliance Certificate For The Year Ended 31.03.2024
Apr 20, 2024, 11:54
Clarification On Price Movement
Apr 10, 2024, 15:56
Clarification sought from ANG Lifesciences India Ltd
Apr 09, 2024, 09:11
Closure of Trading Window
Mar 30, 2024, 13:59
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 16, 2024, 18:03
Disclosure Of Unaudited Financial Results For Quarter And Nine Months Ended 31.12.2023.
Feb 14, 2024, 18:37
Board Meeting Outcome for Outcome Of Board Meeting 14.02.2024.
Feb 14, 2024, 18:34
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Feb 07, 2024, 16:43
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Feb 01, 2024, 17:37
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (The 'Listing Regulations')
Jan 31, 2024, 18:18
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jan 15, 2024, 17:38
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Dec 30, 2023, 17:43

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
41.11
ATR(14)
Less Volatile
5.27
STOCH(9,6)
Neutral
47.19
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.11
ADX(14)
Strong Trend
37.10
UO(9)
Bearish
72.38
ROC(12)
Downtrend But Slowing Down
-0.26
WillR(14)
Overbought
-9.17